Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CARLOS R SANTOS

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1851343578
CMS profile
83470
Location
NORTH MIAMI BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$46,670.10

255 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 5 of 6; records 201–250 of 255 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CARLOS R SANTOS

NPI 1851343578 · CMS profile ID 83470

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

NORTH MIAMI BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 6; records 201–250 of 255 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851343578?year=2022&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CARLOS R SANTOS, NPI 1851343578, CMS profile ID 83470. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 6; records 201–250 of 255 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851343578?year=2022&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CARLOS R SANTOS, NPI 1851343578, CMS profile ID 83470. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 6; records 201–250 of 255 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851343578?year=2022&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CARLOS R SANTOS, NPI 1851343578, CMS profile ID 83470, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 6; records 201–250 of 255 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1851343578?year=2022&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

255 matching records · $46,670.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 255 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 255.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Actelion Pharmaceuticals US, Inc. $9.8703/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885381317 CMS
Harmony Biosciences LLC $47.9303/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955209381 CMS
Regeneron Healthcare Solutions, Inc. $24.0203/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927370911 CMS
Regeneron Healthcare Solutions, Inc. $92.3403/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927370919 CMS
Insmed, Inc. $31.4903/02/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 906430885 CMS
Insmed, Inc. $22.6303/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 906450003 CMS
Regeneron Healthcare Solutions, Inc. $10.7203/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927370903 CMS
AstraZeneca Pharmaceuticals LP $22.6903/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915319521 CMS
JAZZ PHARMACEUTICALS INC. $19.9803/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951344775 CMS
Actelion Pharmaceuticals US, Inc. $33.1102/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885381301 CMS
Bayer HealthCare Pharmaceuticals Inc. $23.3102/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929804565 CMS
Genentech USA, Inc. $16.7702/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950794899 CMS
AstraZeneca Pharmaceuticals LP $90.6002/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915832323 CMS
PFIZER INC. $20.0002/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949071365 CMS
Mylan Specialty L.P. $21.7602/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963895895 CMS
AstraZeneca Pharmaceuticals LP $19.4902/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914771057 CMS
Mallinckrodt Hospital Products Inc. $6.9502/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937523505 CMS
Actelion Pharmaceuticals US, Inc. $22.2602/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885381293 CMS
GlaxoSmithKline, LLC. $650.0002/16/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944377911 CMS
Insmed, Inc. $20.8602/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 906408245 CMS
AstraZeneca Pharmaceuticals LP $16.8802/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915778029 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.7802/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887773341 CMS
GlaxoSmithKline, LLC. $3,900.0002/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944377935 CMS
Regeneron Healthcare Solutions, Inc. $10.7602/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927370895 CMS
Actelion Pharmaceuticals US, Inc. $20.5802/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885381323 CMS
Actelion Pharmaceuticals US, Inc. $31.0302/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885381349 CMS
Amgen Inc. $13.5702/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939428863 CMS
AstraZeneca Pharmaceuticals LP $19.8602/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914707033 CMS
Electromed, Inc. $18.7702/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948222797 CMS
GlaxoSmithKline, LLC. $4.1902/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944377899 CMS
GENZYME CORPORATION $21.8502/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939130895 CMS
AstraZeneca Pharmaceuticals LP $12.2602/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915167279 CMS
Grifols USA, LLC $24.2902/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918658389 CMS
Regeneron Healthcare Solutions, Inc. $10.8402/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927370887 CMS
Paratek Pharmaceuticals, Inc. $19.4101/31/2022 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 881690525 CMS
Harmony Biosciences LLC $44.7301/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955188430 CMS
Inspire Medical Systems, Inc. $797.2401/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959328901 CMS
Bayer HealthCare Pharmaceuticals Inc. $20.4601/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929850187 CMS
GENZYME CORPORATION $22.3101/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939130891 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.9501/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955810427 CMS
GlaxoSmithKline, LLC. $21.4201/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944377877 CMS
Regeneron Healthcare Solutions, Inc. $20.1501/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927370879 CMS
Baxter Healthcare $15.8101/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 888410743 CMS
Amgen Inc. $21.2101/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939428859 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.9401/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887773343 CMS
Actelion Pharmaceuticals US, Inc. $19.6501/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885381325 CMS
Insmed, Inc. $17.6901/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 906437083 CMS
GlaxoSmithKline, LLC. $11.8801/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944377849 CMS
Regeneron Healthcare Solutions, Inc. $15.9201/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927370871 CMS
AstraZeneca Pharmaceuticals LP $18.5801/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914747403 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $31,273.66 291
PY2020 $34,534.27 247
PY2021 $45,667.29 269
PY2022 $46,670.10 255
PY2023 $77,909.32 223
PY2024 $50,181.95 225
PY2025 $25,945.89 255

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $191,665.49 20
PY2024 Principal investigator $115,254.82 18
PY2023 Principal investigator $409.20 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $10,603.80 12/11/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040049
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $136.40 12/10/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040123
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $136.40 12/03/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040121
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $26,119.29 11/13/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040047
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 10/21/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040119
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $10,955.33 10/14/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040045
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $15,034.95 09/17/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040043
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $13,225.73 08/19/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040041
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $8,249.55 08/06/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040039
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 07/16/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040117
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 06/28/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040115
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $14,825.33 06/24/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040037
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $16,586.18 05/22/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040035
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 05/14/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040113
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $8,475.30 04/24/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040033
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $6,800.00 04/17/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040031
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $7,681.95 03/20/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040029
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $43,082.78 03/06/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040027
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $204.60 02/21/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040111
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $9,275.10 01/30/2025 Non-covered Recipient Entity
THE RESEARCH CENTER INC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244040025